Why Astrazeneca (AZN) Dipped More Than Broader Market Today [Yahoo! Finance]
AstraZeneca PLC Ordinary Shares (AZN)
Last astrazeneca plc ordinary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Yahoo! Finance
This change lagged the S&P 500's daily loss of 0.84%. On the other hand, the Dow registered a loss of 0.34%, and the technology-centric Nasdaq decreased by 1.43%. Heading into today, shares of the pharmaceutical had gained 0% over the past month, lagging the Medical sector's gain of 0.16% and the S&P 500's gain of 1.8%. The upcoming earnings release of Astrazeneca will be of great interest to investors. The company's earnings report is expected on February 10, 2026. In that report, analysts expect Astrazeneca to post earnings of $2.18 per share. This would mark year-over-year growth of 107.62%. Meanwhile, the latest consensus estimate predicts the revenue to be $15.71 billion, indicating a 5.48% increase compared to the same quarter of the previous year. AZN's full-year Zacks Consensus Estimates are calling for earnings of $9.17 per share and revenue of $58.61 billion. These results would represent year-over-year changes of +123.11% and 0%, respectively. Investors should also
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC Ordinary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- Harbour BioMed Announces Positive Profit Alert for 2025 Annual Results [Yahoo! Finance]Yahoo! Finance
- Jim Cramer Says “I Like AstraZeneca Very Much” [Yahoo! Finance]Yahoo! Finance
- Walmart hits US$1 trillion in market value for the first time [BNN Bloomberg (Canada)]BNN Bloomberg
- DATROWAY® (datopotamab deruxtecan-dlnk) granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy [Yahoo! Finance]Yahoo! Finance
- DATROWAY® (datopotamab deruxtecan-dlnk) granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapyBusiness Wire
AZN
Sec Filings
- 2/3/26 - Form S-8
- 2/3/26 - Form 6-K
- 2/2/26 - Form 6-K
- AZN's page on the SEC website